Great info indeed... Is there any such technological innovation as an alternative for friends suffering from glaucoma???
On 7/25/15, Aravind R <[email protected]> wrote: > nice info. even if this treatment reaches india, affordability will be > a big issue. > > On 7/25/15, Jyotindra Ganatra <[email protected]> wrote: >> Friends, >> >> I have two adult graduate sons 31/26 years suffering from RP currently in >> Mumbai both lost job due to poor vision, this is to share information. >> Elder one with MBA taking training in NAB Mumbai. >> >> *Surgeons in Manchester have performed the first bionic eye implant in a >> patient with the most common cause of sight loss in the developed world.* >> >> Ray Flynn, 80, has dry age-related macular degeneration which has led to >> the total loss of his central vision. >> >> He is using a retinal implant which converts video images from a miniature >> video camera worn on his glasses. >> >> He can now make out the direction of white lines on a computer screen >> using >> the retinal implant. >> >> Mr Flynn said he was "delighted" with the implant and hoped in time it >> would improve his vision sufficiently to help him with day-to-day tasks >> like gardening and shopping. >> >> *Weed or flower?* >> >> The Argus II implant, manufactured by the US firm Second Sight, has >> previously been used to restore some vision to patients who are blind as a >> result of a rare condition known as retinitis pigmentosa. >> >> The operation, at Manchester Royal Eye Hospital, is the first time it has >> been implanted in a patient with age-related macular degeneration (AMD) >> which affects at least half a million people in the UK to some extent. >> >> I met Ray Flynn last month, on the morning of his surgery and he explained >> that although his retained his peripheral vision, his central sight had >> disappeared. >> >> He said: "I'm unable to put the numbers in for my card when paying in a >> shop or at the bank, and although I was a keen gardener, I can't tell the >> weeds from the flowers anymore." >> >> Ray Flynn's central vision has been lost due to age-related macular >> degeneration >> >> Mr Flynn said he had to sit very close to the television to see anything. >> >> He had given up going to see Manchester United play football as he cannot >> make out what is happening. >> >> The operation took four hours and was led by Paulo Stanga, consultant >> ophthalmologist and vitreo-retinal surgeon at Manchester Royal Eye >> Hospital >> and professor of ophthalmology and retinal regeneration at the University >> of Manchester. >> >> He said: "Mr Flynn's progress is truly remarkable, he is seeing the >> outline >> of people and objects very effectively. >> >> "I think this could be the beginning of a new era for patients with sight >> loss." >> >> *How it works* >> >> The bionic eye implant receives its visual information from a miniature >> camera mounted on glasses worn by the patient. >> >> The images are converted into electrical pulses and transmitted wirelessly >> to an array of electrodes attached to the retina. >> >> The electrodes stimulate the remaining retina's remaining cells which send >> the information to the brain. >> >> In a test, two weeks after surgery, Mr Flynn was able to detect the >> pattern >> of horizontal, vertical and diagonal lines on a computer screen using the >> implant. >> >> He kept his eyes closed during the test so that the medical team could be >> sure that the visual information was coming via the camera on his glasses >> and the implant. >> >> Mr Flynn said: "It was wonderful to be able to see the bars on the screen >> with my eyes closed." >> >> The implant cannot provide any highly detailed vision - but previous >> studies have shown it can help patients to detect distinct patterns such >> as >> door frames and shapes. >> >> Prof Stanga said that in time, Mr Flynn should learn how to interpret the >> images from the implant more effectively. >> >> *Dry AMD* >> >> · There are two forms of age-related macular degeneration - dry >> and >> wet. >> >> · The dry form affects 85% of AMD patients and causes gradual loss >> of central vision, but does not affect peripheral vision. >> >> · The Macular Society estimates that 44,000 people a year in the >> UK >> develop dry AMD. >> >> Four more patients with dry AMD will receive the implant at Manchester >> Royal Eye Hospital, as part of a clinical trial. >> >> Prof Stanga said: "We hope these patients will develop some central visual >> function which they can work in alongside and complement their peripheral >> vision." >> >> We are very excited by this trial and hope that this technology might help >> people, including children with other forms of sight loss." >> >> The Argus II costs about £150,000, including treatment costs, although all >> the patients on the trial will be treated free of charge. >> >> Gregoire Cosendai of Second Sight Medical Products, described the AMD >> study >> as "totally groundbreaking research". >> >> The trial is being held in the Manchester Clinical Research Facility - >> funded by the National Institute for Health Research and Wellcome Trust, >> which aims to bring new drugs and medical devices to patients. >> >> Cathy Yelf, of the Macular Society, said: "This is an exciting result and >> we are following the progress of these trials with great interest. >> >> "Macular degeneration can be a devastating condition and very many people >> are now affected as we live longer. >> >> "These are early trials but in time this research may lead to a really >> useful device for people who lose their central vision." >> >> >> Best Regards, >> Jyotindra Ganatra >> Cell # +971 56 1773940 >> >> >> Register at the dedicated AccessIndia list for discussing accessibility of >> mobile phones / Tabs on: >> http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in >> >> >> Search for old postings at: >> http://www.mail-archive.com/[email protected]/ >> >> To unsubscribe send a message to >> [email protected] >> with the subject unsubscribe. >> >> To change your subscription to digest mode or make any other changes, >> please >> visit the list home page at >> http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in >> >> >> Disclaimer: >> 1. Contents of the mails, factual, or otherwise, reflect the thinking of >> the >> person sending the mail and AI in no way relates itself to its veracity; >> >> 2. AI cannot be held liable for any commission/omission based on the mails >> sent through this mailing list.. >> > > > -- > nothing is difficult unless you make it appear so. > > r. aravind, > > D R O in bank of baroda, > > mobile no: +91 9940369593, > email id : [email protected], [email protected]. > > > > Register at the dedicated AccessIndia list for discussing accessibility of > mobile phones / Tabs on: > http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in > > > Search for old postings at: > http://www.mail-archive.com/[email protected]/ > > To unsubscribe send a message to > [email protected] > with the subject unsubscribe. > > To change your subscription to digest mode or make any other changes, please > visit the list home page at > http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in > > > Disclaimer: > 1. Contents of the mails, factual, or otherwise, reflect the thinking of the > person sending the mail and AI in no way relates itself to its veracity; > > 2. AI cannot be held liable for any commission/omission based on the mails > sent through this mailing list.. > Register at the dedicated AccessIndia list for discussing accessibility of mobile phones / Tabs on: http://mail.accessindia.org.in/mailman/listinfo/mobile.accessindia_accessindia.org.in Search for old postings at: http://www.mail-archive.com/[email protected]/ To unsubscribe send a message to [email protected] with the subject unsubscribe. To change your subscription to digest mode or make any other changes, please visit the list home page at http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in Disclaimer: 1. Contents of the mails, factual, or otherwise, reflect the thinking of the person sending the mail and AI in no way relates itself to its veracity; 2. AI cannot be held liable for any commission/omission based on the mails sent through this mailing list..
